UA92465C2 - Therapeutic uses of inhibitors of rtp801 - Google Patents

Therapeutic uses of inhibitors of rtp801

Info

Publication number
UA92465C2
UA92465C2 UAA200701610A UAA200701610A UA92465C2 UA 92465 C2 UA92465 C2 UA 92465C2 UA A200701610 A UAA200701610 A UA A200701610A UA A200701610 A UAA200701610 A UA A200701610A UA 92465 C2 UA92465 C2 UA 92465C2
Authority
UA
Ukraine
Prior art keywords
rtp801
inhibitors
therapeutic uses
inhibition
protein
Prior art date
Application number
UAA200701610A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Елена Фейнштейн
Клаус Гизе
Йорг Кауфманн
Original Assignee
Кварк Фармасьютикалз Инк.
Сайленс Терапьютикс Аг.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кварк Фармасьютикалз Инк., Сайленс Терапьютикс Аг. filed Critical Кварк Фармасьютикалз Инк.
Publication of UA92465C2 publication Critical patent/UA92465C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides novel molecules, compositions, methods and uses for treating microvascular disorders, eye diseases and respiratory conditions based upon inhibition of the RTP801 gene and/or protein.
UAA200701610A 2004-08-16 2005-08-16 Therapeutic uses of inhibitors of rtp801 UA92465C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04019405 2004-08-16

Publications (1)

Publication Number Publication Date
UA92465C2 true UA92465C2 (en) 2010-11-10

Family

ID=39085993

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200701610A UA92465C2 (en) 2004-08-16 2005-08-16 Therapeutic uses of inhibitors of rtp801

Country Status (6)

Country Link
CN (1) CN102847154A (en)
DK (1) DK1791568T3 (en)
ES (2) ES2390085T3 (en)
GE (1) GEP20125516B (en)
UA (1) UA92465C2 (en)
ZA (1) ZA200701364B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9028298A (en) * 1997-08-21 1999-03-08 Quark Biotech, Inc. Hypoxia-regulated genes
US20070178090A1 (en) * 2003-04-01 2007-08-02 Genzyme Corporation Breast endothelial cell expression patterns
JP2005095173A (en) * 2003-09-04 2005-04-14 Masaomi Nangaku Method for detection of hypoxia response
US20050148496A1 (en) * 2003-11-26 2005-07-07 Entelos, Inc. Treatment of rheumatoid arthritis with hypoxia inducible factor-1alpha antagonists
WO2005056795A2 (en) * 2003-12-03 2005-06-23 Corgentech, Inc. Hif oligonucleotide decoy molecules

Also Published As

Publication number Publication date
ZA200701364B (en) 2008-04-30
ES2691196T3 (en) 2018-11-26
GEP20125516B (en) 2012-05-25
DK1791568T3 (en) 2012-12-10
CN102847154A (en) 2013-01-02
ES2390085T3 (en) 2012-11-06

Similar Documents

Publication Publication Date Title
WO2006023544A3 (en) Therapeutic uses of inhibitors of rtp801
TW200806325A (en) Therapeutic uses of inhibitors of RTP801
WO2007141796A3 (en) Therapeutic uses of inhibitors of rtp801l
MXPA05010711A (en) Novel compounds and compositions as protein kinase inhibitors.
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
TW200630096A (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
MX2009006339A (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity.
TNSN07111A1 (en) Preparation and use of biphenyl-4-yl- carbonylamino acid derivatives for the treatment of obesity.
TW200510334A (en) Preraration and use of aryl alkyl acid derivatives for the treatment of obesity
EA201071245A1 (en) NEW THERAPEUTIC APPROACHES FOR THE TREATMENT OF ALZGEYMER'S DISEASE AND RELATED DISTURBANCES THROUGH MODULATION OF THE STRESS RESPONSE
TW200510416A (en) P38 inhibitors and methods of use thereof
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
EA015654B9 (en) Antibodies against amyloid-beta peptide
NO20072558L (en) Mitotic kinase inhibitors and methods for their use
NO20060392L (en) Combination of SRC kinase inhibitors chemotherapeutic agents for the treatment of proliferative diseases
TW200740808A (en) Inhibiteurs de proteines kinases
MX2021013602A (en) Jak inhibitors.
HK1102626A1 (en) Compositions and methods for the treatment and prevention of hyperproliferative diseases
TW200716561A (en) P38 inhibitors and methods of use thereof
JO2724B1 (en) 3-substituted-5- and 6-Aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors
UA92465C2 (en) Therapeutic uses of inhibitors of rtp801
WO2006078776A3 (en) Inhibitors and methods of treatment of cardiovascular diseases, and methods for identifying inhibitors
ATE482217T1 (en) DITHIOLOPYRROLONE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS
ECSP077260A (en) THERAPEUTIC USES OF RTP801 INHIBITORS